Keith Anthony Jones insider trades: Humacyte (HUMA) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Keith reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | HUMA | ↑ Buy | 10,000 | $0.56 | $6K | Direct | Sep 15, 2026 (1d) |
| Aug 20, 2026 | HUMA | ↑ Buy | 10,000 | $0.69 | $7K | Direct | Aug 21, 2026 (1d) |
| Aug 17, 2026 | HUMA | ↑ Buy | 30,000 | $0.59 | $18K | Direct | Aug 19, 2026 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other HUMA insiders
Open-market trades in the last 12 months
About Keith Anthony Jones's insider trades
Keith Anthony Jones is an insider at Humacyte (HUMA). Since Aug 17, 2026, Keith has reported 3 open-market purchases worth $30K and no sales on SEC Form 4. In the last 12 months: 3 buys ($30K).
Their filings also include grants and awards (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HUMA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.